Related Experiment Videos
Midazolam as intravenous sedative for electrocardioversion.
1Division of Cardiology, Memorial Hospital of Rhode Island, Pawtucket 02860.
Chest
|May 1, 1989
Summary
Midazolam provides safe and effective conscious sedation for electrocardioversion, offering amnesia and fewer complications than diazepam. Careful administration is crucial, especially for patients with respiratory issues.
Area of Science:
- Anesthesiology
- Cardiology
Background:
- Diazepam is commonly used for electrocardioversion sedation but has drawbacks like injection site complications and less amnesia.
- Midazolam, a benzodiazepine, is increasingly used for conscious sedation in various procedures.
Purpose of the Study:
- To evaluate the efficacy and safety of intravenous midazolam for conscious sedation during electrocardioversion.
Main Methods:
- Conscious sedation with intravenous midazolam was administered to 12 patients undergoing 17 electrocardioversions.
- Patients were monitored for adverse effects and procedural outcomes.
Main Results:
- All patients experienced amnesia for the procedure with no significant adverse effects.
- Potential risks include respiratory failure in debilitated patients or those with COPD, necessitating careful administration and monitoring.
Conclusions:
- Intravenous midazolam is a safe and effective alternative for conscious sedation in electrocardioversion when administered with appropriate precautions.
- Its use should be limited to settings equipped to manage potential cardiorespiratory complications.